My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 94

    1.

    Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine.

    Oka T, Tamagawa Y, Hayashida S, Kaneda Y, Kodama N, Tsuji S.

    Biopsychosoc Med. 2007 Nov 15;1:21.PMID: 18001480 [PubMed - in process]Related articlesFree article

    2.

    Relationship between clinical effects of fluvoxamine and the steady-state plasma concentrations of fluvoxamine and its major metabolite fluvoxamino acid in Japanese depressed patients.

    Gerstenberg G, Aoshima T, Fukasawa T, Yoshida K, Takahashi H, Higuchi H, Murata Y, Shimoyama R, Ohkubo T, Shimizu T, Otani K.

    Psychopharmacology (Berl). 2003 Jun;167(4):443-8. Epub 2003 Apr 8.PMID: 12682708 [PubMed - indexed for MEDLINE]Related articles

    3.

    A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder.

    Dannon PN, Iancu I, Lowengrub K, Gonopolsky Y, Musin E, Grunhaus L, Kotler M.

    Clin Neuropharmacol. 2007 Nov-Dec;30(6):326-34.PMID: 18090457 [PubMed - indexed for MEDLINE]Related articles

    4.

    A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.

    Goodyer IM, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, Breen S, Ford C, Barrett B, Leech A, Rothwell J, White L, Harrington R.

    Health Technol Assess. 2008 May;12(14):iii-iv, ix-60.PMID: 18462573 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Upper gastrointestinal tolerability of alendronate sodium monohydrate 10 mg once daily in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled, exploratory study.

    Adachi JD, Faraawi RY, O'Mahony MF, Nayar A, Massaad R, Evans JK, Yacik C.

    Clin Ther. 2009 Aug;31(8):1747-53.PMID: 19808133 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effectiveness of Gorei-san (TJ-17) for treatment of SSRI-induced nausea and dyspepsia: preliminary observations.

    Yamada K, Yagi G, Kanba S.

    Clin Neuropharmacol. 2003 May-Jun;26(3):112-4.PMID: 12782911 [PubMed - indexed for MEDLINE]Related articles

    7.

    Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

    Lenox-Smith AJ, Jiang Q.

    Int Clin Psychopharmacol. 2008 May;23(3):113-9.PMID: 18408525 [PubMed - indexed for MEDLINE]Related articles

    8.

    The herbal medicine Rikkunshi-to stimulates and coordinates the gastric myoelectric activity in post-operative dyspeptic children after gastrointestinal surgery.

    Yagi M, Homma S, Kubota M, Iinuma Y, Kanada S, Kinoshita Y, Ohtaki M, Yamazaki S, Murata H.

    Pediatr Surg Int. 2004 Jan;19(12):760-5. Epub 2004 Jan 9.PMID: 14714134 [PubMed - indexed for MEDLINE]Related articles

    9.

    Gastrointestinal (GI)-Specific patient reported outcomes instruments differentiate between renal transplant patients with or without GI symptoms: results from a South American cohort.

    Machnicki G, Pefaur J, Gaite L, Linchenco AM, Raimondi C, Schiavelli R, Otero A, Margolis MK.

    Health Qual Life Outcomes. 2008 Jul 21;6:53.PMID: 18644133 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant recipients with gastrointestinal tract disorders.

    Darji P, Vijayaraghavan R, Thiagarajan CM, Sharma RK, Subbarao B, Pishardy R, Dakshinamurthy KV, Vijaykumar R, Abraham G, Bhaskar S, Agarwal L, Shah B, Abraham A, John M, Sampathkumar K, Das T, Umesh L, Sundar S, Ballal H, Jasuja S, Saxena S, Saha TK.

    Transplant Proc. 2008 Sep;40(7):2262-7.PMID: 18790208 [PubMed - indexed for MEDLINE]Related articles

    11.

    Pilot study of fluvoxamine treatment for climacteric symptoms in Japanese women.

    Oishi A, Mochizuki Y, Otsu R, Inaba N.

    Biopsychosoc Med. 2007 Jun 5;1:12.PMID: 17547780 [PubMed - in process]Related articlesFree article

    12.

    [Efficacy and tolerability of escitalopram in anxiety disorders: a review]

    Pelissolo A.

    Encephale. 2008 Sep;34(4):400-8. Epub 2008 Aug 15. Review. French. PMID: 18922243 [PubMed - indexed for MEDLINE]Related articles

    13.

    Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.

    Khandker RK, Kruzikas DT, McLaughlin TP.

    J Manag Care Pharm. 2008 Jun;14(5):426-41.PMID: 18597572 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study.

    Hurwitz BJ, Jeffery D, Arnason B, Bigley K, Coyle P, Goodin D, Kaba S, Kirzinger S, Lynch S, Mandler R, Mikol D, Rammohan K, Sater R, Sriram S, Thrower B, Boateng F, Jakobs P, Wash MB, Bogumil T.

    Clin Ther. 2008 Jun;30(6):1102-12.PMID: 18640466 [PubMed - indexed for MEDLINE]Related articles

    15.

    Efficacy and tolerability of Hypericum perforatum in major depressive disorder in comparison with selective serotonin reuptake inhibitors: a meta-analysis.

    Rahimi R, Nikfar S, Abdollahi M.

    Prog Neuropsychopharmacol Biol Psychiatry. 2009 Feb 1;33(1):118-27. Epub 2008 Nov 12.PMID: 19028540 [PubMed - indexed for MEDLINE]Related articles

    16.

    Duloxetine: a review of its use in the treatment of generalized anxiety disorder.

    Carter NJ, McCormack PL.

    CNS Drugs. 2009;23(6):523-41. doi: 10.2165/00023210-200923060-00006. Review.PMID: 19480470 [PubMed - indexed for MEDLINE]Related articles

    17.

    Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.

    Lizogub VG, Riley DS, Heger M.

    Explore (NY). 2007 Nov-Dec;3(6):573-84.PMID: 18005909 [PubMed - indexed for MEDLINE]Related articles

    18.

    Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial.

    Clauw DJ, Mease P, Palmer RH, Gendreau RM, Wang Y.

    Clin Ther. 2008 Nov;30(11):1988-2004. Erratum in: Clin Ther. 2009 Jul;31(7):1617. Clin Ther. 2009 Feb;31(2):446. PMID: 19108787 [PubMed - indexed for MEDLINE]Related articles

    19.

    A comparison of initial duloxetine dosing strategies in patients with major depressive disorder.

    Whitmyer VG, Dunner DL, Kornstein SG, Meyers AL, Mallinckrodt CH, Wohlreich MM, Gonzales JS, Greist JH.

    J Clin Psychiatry. 2007 Dec;68(12):1921-30.PMID: 18162024 [PubMed - indexed for MEDLINE]Related articles

    20.

    Intravenous augmentative citalopram versus clomipramine in partial/nonresponder depressed patients: a short-term, low dose, randomized, placebo-controlled study.

    Altamura AC, Dell'Osso B, Buoli M, Zanoni S, Mundo E.

    J Clin Psychopharmacol. 2008 Aug;28(4):406-10.PMID: 18626267 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination
    Write to the Help Desk